




















An unusual interventricular septal bounce in
a patient with dermatomyositis: a case report
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Background In literature it has been reported in 1998, for the first time, a case of a 54-year-old man who developed constrict-
ive pericarditis (CP) 12 years after diagnosis of dermatomyositis (DM). To our knowledge, this may be the only
case reported.
...................................................................................................................................................................................................
Case summary A 16-year-old man presented to our institution because of symptoms posing a suspicion for an inflammatory dis-
ease; after physical examination, lab tests, and other investigations (electromyography, magnetic resonance, and
muscular biopsy) was diagnosed as having DM. Patient also showed hepatomegaly and congested jugular veins: after
clinical and imaging investigations (transthoracic echocardiography and transoesophageal echocardiography) he was
diagnosed as having a CP. Patient underwent pericardial resection and the final outcome consisted of a completely
regression of the symptoms.
...................................................................................................................................................................................................
Discussion Cardiac involvement in patients with DM ranges between 6% and 75%, and it can be clinically manifest or, far more
frequently, sub-clinic. Pericardial involvement as a complication of DM is widely reported in the literature, but in al-
most all cases as acute pericarditis, effusive pericarditis or cardiac tamponade and almost never as a CP.
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Introduction
Dermatomyositis (DM) is a systemic idiopathic inflammatory
myopathy, characterized by an inflammatory infiltrate primarily
affecting skeletal muscle and skin, with typical cutaneous lesions2
accompanying, or more often preceding, muscle weakness.
The reported incidence of DM ranges from 1.2 to 17 new cases
per 1 000 000 inhabitants with a prevalence between 5 and 11
cases per 100 000 individuals.3 Dermatomyositis typically demon-
strates a bimodal age distribution with both juvenile and adult
forms.4
Pericardial involvement is less common in DM than other
connective tissue diseases (<10%) and it nearly always manifests
as acute pericarditis, pericardial effusion and cardiac tam
ponade.5 To our knowledge, only one published case of con-
strictive pericarditis (CP) in DM6 is available in the medical
literature.
Learning points
• Constrictive pericarditis may be a complication of
dermatomyositis.
• The interventricular septum bulging (or septal bounce)
detected by echocardiography is the most striking finding of
this type of complication.
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A 16-year-old man was referred to our institution with progressive
weakness and arthralgia, mainly involving proximal part of superior
limbs. He developed these symptoms during the last 3 months in as-
sociation with intermittent fever and weight loss. As the patient
reported, a skin rash was present for 6 months. He had not received
any therapy for these symptoms and signs.
At admission he had a temperature of 37.4C. Physical examin-
ation demonstrated significant hepatomegaly. Mucocutaneous exam-
ination showed lichenoid papules on the dorsal surface of the hands,
typical of Gottron papules.
His jugular venous pressure was raised and his heart sounds were
normal. The chest was clear to auscultation. His blood pressure was
90/60 mmHg with a heart rate of 82 b.p.m. The respiratory rate was
16 breaths per minute and the oxygen saturation was 98%.
Blood investigations revealed:
• High alanine transaminase (78 IU/l) (reference range <35 IU/l)
• Very high creatine phosphokinase (736 UI/l) (reference range 60–
174)
• Positive Rose-Waaler test.
• Positive anti-Jo1 antibody
• High NT-proBNP (3150 ng/l) (upper limit of normal: 900 ng/l).
In the proximal muscles, electromyography showed small, short,
polyphasic actions potentials, with early recruitment motor unit ac-
tion potentials, indicative of membrane irritability. These findings
were more pronounced in the upper limbs. These findings suggested
a diagnosis of DM.
A right quadriceps femoris biopsy showed B cells inflammatory
infiltrated involving perivascular spaces and interfascicular septae,
compatible with muscle fibre degeneration due to microvascular
damage.
Muscular magnetic resonance showed generalized muscular oe-
dema associated with atrophy and adipose infiltration.
The patient was diagnosed as having DM (Bohan and Peter’s crite-
ria)7 and was started on corticosteroids therapy (1 mg/kg/day of oral
15 January 2016 Hospitalization
Clinical history Constitutional symptoms (started 3 months before): progressive weakness and arthralgia




HR 82 b.p.m. (regular)
Lower limb oedema
Labs Positive anti-Jo1 antibodies
Increase of alanine transaminase and creatine phosphokinase
Investigations (results) Electromyography (pattern suggestive of dermatomyositis)
Muscular magnetic resonance (generalized muscular oedema, atrophy, and adipose infiltration).
Muscular biopsy (muscle fibre degeneration due to microvascular damage)
Diagnosis Dermatomyositis
Treatment Corticosteroids and methotrexate
Time two (20 January 2016) Cardiac evaluation
Investigations and results Electrocardiogram Sinus rhythm and multiple ventricular premature beats
Transthoracic echocardiogram Interventricular septal bounce
Significant reduction in mitral inflow velocity and an increase of tricus-
pid inflow velocity during inspiration
Tissue Doppler imaging-E Normal e0 velocity from the medial mitral annulus (12 cm/s)
Transoesophageal echocardiogram Interventricular septal bounce
Markedly thickened and calcified pericardium
Diagnosis Constrictive pericarditis
21 February 2016 Treatment
Surgical treatment Pericardial resection
21 April 2016 Outcome
After pericardial resection cardiovascular symptoms disappeared and patient went back to normal life
20 February 2018 2 years follow-up
Patient was asymptomatic with a NYHA class 1






















































..prednisolone) together with methotrexate (15 mg, orally, once a
week).
The 12-leads electrocardiogram showed a sinus rhythm with mul-
tiple ventricular premature beats.
The transthoracic echocardiogram (TTE) showed an atypical inter-
ventricular septal bounce into the left ventricular cavity because of
ventricular interaction (Supplementary material online, Video S1). Left
ventricle and right ventricle (RV) systolic function was normal.
Transoesophageal echocardiogram showed a markedly thickened
and calcified pericardium and demonstrated very clearly the interven-
tricular septal bounce (Supplementary material online, Video S2).
TTE-transvalvular PW Doppler flow studies showed a significant
reduction of 31% in mitral inflow velocity and an increase of 25% in
tricuspid inflow velocity during inspiration (Figures 1 and 2). The in-
crease in tricuspid flow during inspiration was less significant than mi-
tral inflow velocity reduction. In contrast, an increase of mitral inflow
velocity was noted during expiration with a reduced filling velocity to
the right heart (Figures 1 and 2). The aortic flow velocity decreased
during inspiration and increased during expiration.
Tissue Doppler imaging (TDI) showed a medial e0 velocity of
12 cm/s and a lateral e0 velocity of 9 cm/s (annulus reversus). E/e0
ratio (using average e0) was 9 (annulus paradoxus).
The echocardiographic findings were in keeping with constrictive
pericarditis (CP).8
Patient was diagnosed as having a CP.
At the time of diagnosis the NYHA class was 3 (dyspnoea induced
by mild exertion).
The patient underwent radical pericardiectomy by total median
sternotomy without significant post-operative complications.
He was discharged on day 10 with a medical therapy consisting of
diuretics (furosemide orally 20 mg BID); corticosteroids (5 mg per
day of oral prednisone), methotrexate (15 mg orally, once per week),
antibiotics (amoxicillin orally 3 g/day for 2 weeks) and paracetamol
(maximum 4000 mg/day, orally). Hepatomegaly disappeared 4 weeks
after operation together with alanine transaminase normalization.
After pericardial resection, the interventricular septum bulging and
the respiratory variation of filling velocities completely disappeared
(Supplementary material online, Video S3) (see also Table 1).
On follow-up 2 years later, the patient had no symptoms.
Discussion
In 1899 Oppenheim reported for the first time, according to the cur-
rent literature, cardiac involvement in polymyositis and DM.9
The pathophysiology of pericardial involvement is similar in all sys-
temic inflammatory diseases. Immune complexes and inflammatory
cytokines, such as vascular endothelial growth factor (VEGF) and
basic fibroblast growth factor, seem to be related to pericardial in-
volvement, even if their role is not completely cleared.10
Karatolios et al. report that the concentrations of VEGF in pericar-
dial effusion and serum blood were significantly greater in subjects
with systemic autoimmune inflammatory disease than in those with
coronary artery disease. They also found VEGF levels in pericardial
effusion positively correlated with markers of pericardial inflamma-
tion, such as lactate dehydrogenase and leucocytes.11 Chronic inflam-
mation may lead to fibrosis, calcification and organization of
pericardial fluid with a possible evolution towards pericardial
constriction.5
Approximately 5–15% of patients with acute or recurrent pericar-
ditis may have a systemic autoimmune disease, either overt or under-
lying. Pericardial involvement is common in all connective tissue
Figure 1 Respiratory variation of mitral inflow.



























































.diseases, rheumatoid arthritis and systemic vasculitis, but it might be
less common in sarcoidosis and inflammatory bowel diseases. More
specifically, while CP may complicate the rheumatoid arthritis, we
know it is extremely rare in systemic lupus erythematosus.12
In DM, pericardial involvement usually expresses itself as an acute
pericarditis, pericardial effusion, and cardiac tamponade.5
In 1998, Tamir et al.6 reported, for the first time, a case of a 54-
year-old man who developed CP 12 years after the diagnosis of DM.
The patient presented with progressive weakness, anasarca, and
moderate anaemia. To our knowledge, this may be the only case like
ours ever reported.
The patient’s clinical history may raise a discussion about the rela-
tively rapid development of the constriction picture, within 3 months
from the constitutional symptoms onset, even if the patient pre-
sented an indefinite skin rash for 6 months. The 2015 ESC Guidelines
for the diagnosis and management of pericardial diseases13 reported
that the delay between the initial pericardial inflammation and the
onset of pericardial constriction is variable and that it is possible to
define the clinical picture as persistent constriction after 3–6 months
from the onset of symptoms.
Imazio et al.14 reported that a warning sign of a possible rapid evo-
lution towards CP is a failure of empirical anti-inflammatory therapy.
For this reason, in our patient, a lack of specific therapy in the previ-
ous 3 months may have lead to a rapid development of CP.
An important issue is how to correctly diagnose pericardial
constriction.
Oh et al.8 described very accurately the echo-Doppler features of
pericardial constriction compared with myocardial restriction.
In CP, the most striking findings are ventricular septal motion
abnormalities (septal bounce), which do not occur in restriction.15 In
the reported case, this finding allowed us to make an early diagnosis.
Respiratory variation in ventricular filling arises from the dissoci-
ation of intrathoracic and intracardiac pressure change and enhanced
ventricular interaction in CP. As we know, inspiration reduces
intrathoracic pressure which usually is fully transmitted to intracar-
diac pressures. On the contrary, in constriction, the intracardiac pres-
sures fall much less than intrathoracic pressure because of pericardial
constraint.
This difference in pressure change with inspiration results in
reduced filling to left side of the heart. The reduction in left heart fill-
ing during inspiration causes a reduction in mitral inflow velocity and
a shift of the interventricular septum towards the left ventricle. With
expiration, left heart filling increases which shifts the interventricular
septum back towards the RV, leading to reduced filling to right side of
the heart and a late-diastolic reversal of flow in the hepatic veins.
In CP the e0 velocity from TDI of the medial mitral annulus is 9 cm/
s or greater while it is usually 6 cm/s or less in patients with a restrict-
ive cardiomyopathy. Furthermore, the medial mitral annular e0 vel-
ocity is usually greater than the lateral mitral annular e0, since the
lateral motion of the heart is limited by the constrictive pericardium.
This finding is recognized as “annulus reversus”.8 This again stands in
contrast to what is expected in other forms of heart failure, and may
reflect tethering of the lateral annulus by the constrictive process.8
Despite elevated LV filling pressures (restrictive transmitral flow pat-
tern) E/e0 remains low in CP (annulus paradoxus). These findings, to-
gether with an inferior vena cava plethora and little respiratory
variations, are important echocardiographic signs of pericardial con-
striction.8 As reported in the European Association of Cardio-
Vascular Imaging (EACVI) position paper,15 other imaging techniques
are useful to make a diagnosis of pericardial constriction. Cardiac
computed tomography and cardiac magnetic resonance (CMR) usu-
ally detect very accurately pericardial calcification and, in a clinical set-
ting of suspected constriction, they have an essential role in making a
correct diagnosis. However, calcification alone does not allow making
a diagnosis of ‘pericardial constriction’. In addition, real-time cine
CMR demonstrates dilated right atrium, elongated RV and ventricular
interdependence.15 At the same time, pericardial adhesions between
the thickened pericardium and the epicardial surface of the
Figure 2 Respiratory variation of tricuspid inflow.






















































..myocardium with reduced mobility of the myocardium may be high-
lighted by tagged cine CMR imaging.15
Conclusion
It is well known that, among cardiovascular complications due to
DM, pericardial involvement is rare and usually it manifests as acute
pericarditis, pericardial effusion, and/or cardiac tamponade. The
reported case demonstrates that CP is a possible complication of
DM. A very important point is to correctly using all imaging techni-
ques today available in order to make a correct diagnosis of pericar-
dial constriction.
Supplementary material
Supplementary material is available at European Heart Journal - Case
Reports online.
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